Incyte announced the appointment of Christiana Stamoulis as Executive Vice President and Chief Financial Officer, effective February 11, 2019. Ms. Stamoulis will succeed David Gryska who, as planned, retired from company at the end of 2018. Ms. Stamoulis has over 20 years of experience in the biotechnology industry.

She joins Incyte from Unum Therapeutics, where she was President and Chief Financial Officer. Prior to Unum, she was the Senior Vice President of Corporate Strategy and Business Development at Vertex Pharmaceuticals.